Discipline | Infectious disease |
---|---|
Language | English |
Edited by | Andreas J. Bäumler |
Publication details | |
History | 1967–present |
Publisher | American Society for Microbiology (United States) |
Frequency | Monthly |
Delayed | |
2.9 (2023) | |
Standard abbreviations | |
ISO 4 | Infect. Immun. |
Indexing | |
CODEN | INFIBR |
ISSN | 0019-9567 (print) 1098-5522 (web) |
LCCN | 70234261 |
OCLC no. | 01753126 |
Links | |
Infection and Immunity is a peer-reviewed medical journal published by the American Society for Microbiology. It focuses on interactions between bacterial, fungal, or parasitic pathogens and their hosts. Areas covered include molecular pathogenesis, cellular microbiology, bacterial infection, host responses and inflammation, fungal and parasitic infections, microbial immunity and vaccines, and molecular genomics. The journal publishes primary research articles, editorials, commentaries, minireviews, and a spotlight report highlighting articles of particular interest selected by the editors. Articles are freely accessible after 6 months (delayed open access). Through its "Global Outreach Program," free online access is available to qualified microbiologists in eligible developing countries.
The journal was established in 1970. Prior to that time, original research articles covering topics in infection and immunity were published in a section of the Journal of Bacteriology . As the size of this section grew, the need for a separate journal publishing peer-reviewed research in this area became apparent. [1] The first editor-in-chief was Erwin Neter (SUNY Buffalo).
The following persons have been editor-in-chief of Infection and Immunity:[ citation needed ]
The journal is abstracted and indexed in:
According to the Journal Citation Reports , the journal has a 2023 impact factor of 2.9. [2]
Antimicrobial Agents and Chemotherapy is a peer-reviewed scientific journal published by the American Society for Microbiology. It covers antimicrobial, antiviral, antifungal, and antiparasitic agents and chemotherapy. The editor-in-chief is Cesar A. Arias. It was established in 1972 by Gladys Lounsbury Hobby.
Clinical and Vaccine Immunology (CVI) was a peer-reviewed journal published by the American Society for Microbiology. CVI enhances our understanding of the immune response in health and disease by showcasing important clinically relevant research, including new animal models for human immunologic diseases, viral immunology, immunopathogenesis, and clinical laboratory immunology. In particular, the journal highlights important discoveries in immunization and vaccine research, such as the development and evaluation of vaccines, human and animal immune responses to vaccines, vaccine vectors, adjuvants and immunomodulators, quantitative assays of vaccine efficacy, and clinical trials. The journal publishes primary research articles, editorials, commentaries, minireviews, and case reports. Articles are freely accessible after six months. Through its "Global Outreach Program", free online access is available to qualified microbiologists in eligible developing countries.
Clinical Microbiology Reviews is a peer-reviewed medical journal covering the areas of clinical microbiology, immunology, medical microbiology, infectious diseases, veterinary microbiology, and microbial pathogenesis. It is a delayed open access journal, full content is accessible via PubMed Central and the journal's website after a 12-month embargo. In April 2015, the journal transitioned to a continuous online publication model. The journal became online-only in January 2018. The final print issue was published in October 2017. According to the Journal Citation Reports, the journal has a 2021 impact factor of 50.129. The journal was established in January 1988. The founding editor was Josephine A. Morello. Editorial board structure changed in 1992 and Morello became editor-in-chief. Betty Ann Forbes was appointed editor-in-chief in 1997. Irving Nachamkin was appointed editor-in-chief in 2002 until 2012. Jo-Anne H. Young served as editor-in-chief from 2012 to 2022. The current editor-in-chief is Graeme Forrest. It is the ninth journal established and published by the American Society for Microbiology.
Australian Systematic Botany is an international peer-reviewed scientific journal published by CSIRO Publishing. It is devoted to publishing original research, and sometimes review articles, on topics related to systematic botany, such as biogeography, taxonomy and evolution. The journal is broad in scope, covering all plant, algal and fungal groups, including fossils.
Clinical Infectious Diseases is a peer-reviewed medical journal published by Oxford University Press covering research on the pathogenesis, clinical investigation, medical microbiology, diagnosis, immune mechanisms, and treatment of diseases caused by infectious agents. It includes articles on antimicrobial resistance, bioterrorism, emerging infections, food safety, hospital epidemiology, and HIV/AIDS. It also features highly focused brief reports, review articles, editorials, commentaries, and supplements. The journal is published on behalf of the Infectious Diseases Society of America. The editor-in-chief is infectious disease physician Paul Sax.
The Journal of Infectious Diseases is a peer-reviewed biweekly medical journal published by Oxford University Press on behalf of the Infectious Diseases Society of America. It covers research on the pathogenesis, diagnosis, and treatment of infectious diseases, on the microbes that cause them, and on immune system disorders. Cynthia Sears, an expert on gut infections, was appointed editor-in-chief in 2023.
Journal of General Virology is a not-for-profit peer-reviewed scientific journal published by the Microbiology Society. The journal was established in 1967 and covers research into animal, insect and plants viruses, also fungal viruses, prokaryotic viruses, and TSE agents. Antiviral compounds and clinical aspects of virus infection are also covered.
Virology is a peer-reviewed scientific journal in virology. Established in 1955 by George Hirst, Lindsay Black and Salvador Luria, it is the earliest English-only journal to specialize in the field. The journal covers basic research into viruses affecting animals, plants, bacteria and fungi, including their molecular biology, structure, assembly, pathogenesis, immunity, interactions with the host cell, evolution and ecology. Molecular aspects of control and prevention are also covered, as well as viral vectors and gene therapy, but clinical virology is excluded. As of 2013, the journal is published fortnightly by Elsevier.
Gerald Domingue is an American medical researcher and academic who served as Professor of Urology, Microbiology and Immunology in the Tulane University School of Medicine and Graduate School for thirty years and also as Director of Research in Urology. He is currently retired and resides in Zürich, Switzerland, where he is engaged in painting and creative writing. At retirement he was honored with the title of Professor Emeritus at Tulane (1967–1997). Prior to Tulane, he was faculty of Saint Louis University School of Medicine); was a lecturer at Washington University School of Dentistry and director of clinical microbiology in St. Louis City Hospital, St. Louis, Missouri.
The Journal of Medical Microbiology is a monthly peer-reviewed medical journal covering all aspects of microbiology relevant to human and animal disease, including pathogenicity, virulence, host response, epidemiology, microbial ecology, diagnostics, etc., relating to viruses, bacteria, fungi, and eukaryotic parasites. It is published by the Microbiology Society and the editors-in-chief are Norman Fry and Kalai Mathee. The journal publishes primary research articles, reviews, short communications, personal views, and editorials.
The Annual Review of Immunology is a peer-reviewed scientific journal published by Annual Reviews. It releases an annual volume of review articles relevant to the field of immunology. It was first published in 1983 with inaugural editor William E. Paul; Paul remained editor for the journal's first thirty years. As of 2022, its editor is Wayne M. Yokoyama. As of 2023, Annual Review of Immunology is being published as open access, under the Subscribe to Open model. As of 2023, Journal Citation Reports gives the journal a 2022 impact factor of 29.7, ranking it fourth of 161 journals in the category "Immunology".
Victor Nizet is an American microbiologist who is a professor of pediatrics. He is a Distinguished Professor and Vice Chair of Basic Research at the Department of Pediatrics at the University of California, San Diego (UCSD) School of Medicine. He is also a Distinguished Professor at UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences in La Jolla, California. He is known for his research in the areas of molecular microbiology and the innate immune system, with a particular focus on infectious diseases caused by common Gram-positive bacterial pathogens such as Group A Streptococcus, Group B Streptococcus and Staphylococcus aureus.
Molecular Microbiology is a bimonthly peer-reviewed scientific journal covering all aspects of molecular microbiology. It was established in 1987 and is published by Wiley-Blackwell. The editor-in-chief is John D. Helmann.
Infection is a bimonthly peer-reviewed medical journal published by Springer Science+Business Media. It covers research on infectious diseases, including etiology, pathogenesis, diagnosis, and treatment in outpatient and inpatient settings.
In biology, a pathogen, in the oldest and broadest sense, is any organism or agent that can produce disease. A pathogen may also be referred to as an infectious agent, or simply a germ.
Medical Microbiology and Immunology is a peer-reviewed medical journal covering all aspects of the interrelationship between infectious agents and their hosts, with microbial and viral pathogenesis and the immunological host response to infections in particular as major topics. It is published by Springer and was established in 1886 by Robert Koch and Carl Flügge, who were the first editors-in-chief for more than 20 years. Originally named “Zeitschrift für Hygiene”, it was renamed multiple times in the light of scientific and medical advances and the emergence of new research disciplines, before adopting its current name Medical Microbiology and Immunology in 1971. The current editors-in-chief are V.A.J. Kempf (Bacteriology), M.J. Reddehase (Virology) and C. Bogdan (Immunology).
Arturo Casadevall is a Bloomberg Distinguished Professor of Molecular Microbiology & Immunology and Infectious Diseases at the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine, and the Alfred and Jill Sommer Professor and Chair of the W. Harry Feinstone Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health. He is an internationally recognized expert in infectious disease research, with a focus on fungal and bacterial pathogenesis and basic immunology of antibody structure-function. He was elected a member of the National Academy of Sciences in 2022.
B. Brett Finlay, is a Canadian microbiologist well known for his contributions to understanding how microbes cause disease in people and developing new tools for fighting infections, as well as the role the microbiota plays in human health and disease. Science.ca describes him as one of the world's foremost experts on the molecular understanding of the ways bacteria infect their hosts. He also led the SARS Accelerated Vaccine Initiative (SAVI) and developed vaccines to SARS and a bovine vaccine to E. coli O157:H7. His current research interests focus on pathogenic E. coli and Salmonella pathogenicity, and the role of the microbiota in infections, asthma, and malnutrition. He is currently the UBC Peter Wall Distinguished Professor and a Professor in the Michael Smith Laboratories, Microbiology and Immunology, and Biochemistry and Molecular Biology, and Co-director and Senior Fellow for the CIFAR Humans and Microbes program. He is also co-author of the book Let Them Eat Dirt: Saving Your Child from an Oversanitized World and The Whole-Body Microbiome: How to Harness Microbes - Inside and Out - For Lifelong Health. Finlay is the author of over 500 publications in peer-reviewed journals and served as editor of several professional publications for many years.
The retraction index is a measure of how likely an article published in a given academic journal will be retracted. It is calculated by multiplying the number of retracted articles in a journal during a given time period by 1,000, and then dividing the result by the total number of articles published in that journal during the same period. The term was coined in a 2011 editorial by Ferric Fang and Arturo Casadevall, the co-editors-in-chief of the journal Infection and Immunity. In their original editorial, Fang and Casadevall also showed a strong positive correlation between a journal's retraction index and its impact factor. Among the 17 journals they analyzed, the New England Journal of Medicine had the highest retraction index. The New England Journal of Medicine responded to the Feng and Casadevall editorial with a statement criticizing it for only considering papers with abstracts. The statement argued that because most articles published in each issue of the Journal do not have abstracts, the journal's retraction index appeared artificially high. They did not identify a mechanism for why this relationship might exist, but suggested that it might be because researchers are more willing to cut corners to get a paper published in a higher-impact journal.
Microorganisms is a peer-reviewed open-access scientific journal that covers various areas of microbiological research, including microbial taxonomy, molecular biology, genetics, and ecology. It is published by MDPI and was established in 2013. The editor-in-chief is Martin Von Bergen.